Adagene is an antibody discovery and development biotechnology company specializing in oncology immunotherapy. It is creating a pipeline of mono-specific and bi-specific antibody therapeutics with the help of computational biology and artificial intelligence.
Revenue (FY, 2019)
Revenue growth (FY, 2018 - FY, 2019), %
Net income (FY, 2019)
EBIT (FY, 2019)
Market capitalization (8-Sept-2021)
Closing stock price (8-Sept-2021)
|Company Name||Date||Deal Size|
|ADAGENE AUSTRALIA PTY LTD|
|Adagene (Hong Kong) Limited|
|ADAGENE PTE. LTD.|
|Adagene (Suzhou) Limited|
When was Adagene founded?
Adagene was founded in 2012.
Who are Adagene key executives?
Adagene's key executives are Man Kin Tam, Felix Du and Peter Luo.
How many employees does Adagene have?
Adagene has 198 employees.
What is Adagene revenue?
Latest Adagene annual revenue is $480 k.
What is Adagene revenue per employee?
Latest Adagene revenue per employee is $2.4 k.
Who are Adagene competitors?
Competitors of Adagene include Shanghai Henlius Biotech, Anavex and UT Health San Antonio MD Anderson Cancer Center.
Where is Adagene headquarters?
Adagene headquarters is located at 4f, building c14, no, 218 Xinghu St, Wuzhong Qu, Suzhou.
Where are Adagene offices?
Adagene has offices in Suzhou, San Diego and San Francisco.
How many offices does Adagene have?
Adagene has 3 offices.
Receive alerts for 300+ data fields across thousands of companies